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Inpathologicalconditionswithconcurrentneutrophilia,modiﬁcationsof erythrocyte membrane proteins are reported. In chronic
myeloid leukemia (CML),a myeloproliferative disease wherein neutrophilia is accompanied by enhanced erythrophagocytosis, we
report for the ﬁrst time excessive cleavage of erythrocyte band 3. Distinct fragments of band 3 serve as senescent cell antigens
leading to erythrophagocytosis. Using immunoproteomics,we report the identiﬁcation of immunogenic43kDa fragmentof band
3 in 68% of CML samples compared to their detection in only 38% of healthy individuals. Thus, excessive fragmentation of band
3 in CML, detected in our study, corroborated with the eryptotic phenotype. We demonstrate the role of neutrophilic cathepsin
G, detected as an immunogen on erythrocyte membrane, in band 3 cleavage. Cathepsin G from serum adsorbs to the erythrocyte
membrane to mediate cleavage of band 3 and therefore contribute to the eryptotic phenotype in CML.
1.Introduction
Neutrophils are inﬂammatory cells which contribute to tis-
sue repair. Antithetically, neutrophilia and associated eﬀects
of the neutrophilic proteases and oxidases can lead to addi-
tional pathology at the site of inﬂammation [1]. In patients
with cardiovascular disease [2], ischemic stroke [3], and in
pregnancy [4], neutrophilia co-occurs with modiﬁcations
of erythrocyte membrane protein band 3, which is either
aggregated or cleaved. The modiﬁed band 3 is a senescent
cell antigen, which can mediate immune recognition and
erythrophagocytosis [5, 6].
Neutrophilicproteases, mainly elastase, have been shown
to cleave erythrocyte membrane proteins. Santos-Silva et al.
[7] have demonstrated that cellular aging and incubation
either with activated neutrophils or with neutrophilic elas-
tase lead to aggregation of band 3 which they suggest could
be due to cross-linking of proteolytic fragments [3]. In an
in vitro study, neutrophilic elastase and cathepsin G are re-
ported to degrade glycophorins on erythrocyte membrane
[8]. The same group has shown degradation of glycophorins
on the surface of erythrocytes from patients with myelopro-
liferative disease and attributed it to elastase [9]. Our study
for the ﬁrst time demonstrates the role of cathepsin G in the
cleavage of erythrocyte band 3 in chronic myeloid leukemia
(CML).
CMLisaprogressivemyeloproliferativeconditionmarked
by neutrophilia, and patients also suﬀer from moderate to
mild anemia. Altered proﬁle of membrane-skeletal pro-
teins in CML erythrocytes [10] leads to the expression of
aggregated band 3 on cell surface and in turn enhances
erythrophagocytosisin vitro [11]. Incontrary to the reported
aggregation [11], we observed excessively cleaved band 3 in
majority of CML samples. Since distinct fragments of band 3
are recognized by serum IgG and thus induce erythrophago-
cytosis [12], we used immunoproteomics approach to iden-
tify the immunogens recognized by serum IgG in the mem-
branes of CML erythrocytes. Fragments of band 3 as well
as cathepsin G, which is a neutrophilic serine protease [13],
were detected as antigens in the membranes of mainly CML2 Anemia
erythrocytes. The in vitro studies to conﬁrm the causal role
of membrane-bound cathepsin G in proteolysis of band 3 is
described.
2.Materialsand Methods
2.1. Chemicals. Pepstatin A (P 4265), phenyl methyl sulfonyl
ﬂuoride (PMSF) (P 7626), sequencing grade trypsin (T
6567), and anti-band 3 N-terminus monoclonal antibody
(B 9277) were purchased from Sigma-Aldrich Inc, USA.
CathepsinG inhibitor1 (219372)was procuredfromCalbio-
chem, USA. Antibodies to cathepsin G; band 3 (polyclonal);
protein kinase C (PKC) βII were from Abcam plc, UK
(ab50845);Abnova,Taiwan (HOOOO6521-B01)Boehringer
Mannheim, Germany (1471864), respectively. Enhanced
chemiluminescence (ECL) plus (RPN 2132), protein G se-
pharose CL-4B (17-0780-01), and horse-radish peroxidase-
(HRP-) conjugated secondary antibodies: anti-mouse (NA
931), anti-rabbit (NA 934), and anti-human (NA 933) IgGs
were from GE Healthcare, UK. Polyvinylidene diﬂuoride
(PVDF) membrane (IPVH 00010) was from Millipore
India Pvt. Ltd., India. Melon gel IgG puriﬁcation kit
(45206) was from Pierce Biotechnology, USA. α-Cyano-4-
hydroxycinnamic acid (CHCA) (201344) was from Bruker
Daltonics, Germany. Fluorescein-isothiocyanate-(FITC-)
labelled anti-CD 15 (347423), anti-CD 45 (555482), anti-
bodies were from BD Pharmingen, USA.
2.2. Biological Material. This study was undertaken after
obtaining ethics clearance from the hospital ethics commit-
tee, and informed consent form was administered prior to
sample collection. Peripheral blood (5mL) was collected
by venipuncture in ethylene-diamine-tetra-acetic-acid-
(EDTA)-containing bulbs for separation of erythrocytes and
non-EDTA containing bulbs for obtaining serum. Patients
with conﬁrmed diagnosis of CML-chronic phase, who
receivedno prior treatment for the disease, were recruitedfor
thestudy(n = 18).Patientinformationonage,sex,leukocyte
count,andhemoglobinlevelsisgiveninSection 1ofthesup-
plementary information. Healthy voluntary donors (N) who
reported no health problems served as controls (n = 14).
2.3.Preparation ofErythrocyteSuspension. Erythrocyteswere
allowed to settle from the blood sample collected in EDTA
bulbs. After removing the supernatant plasma, erythrocytes
were washed three times in wash buﬀer (10mM Tris pH
7.6, 150mM NaCl) (1:40v/v) separating them each time
by centrifugation at 1500rpm for 15min at 4◦C. The extent
of neutrophil contamination in erythrocytes separated using
this protocol was assessed by detection of CD 45- and CD
15-labelled cells by ﬂow cytometry as detailed in Section 2 of
supplementary information. The neutrophil contamination
w a sl e s st h a n0 . 0 1 %i nt h ee r y t h r o c y t ep r e p a r a t i o n .
2.4. Preparation of Membrane and Cytosol Fractions. The
erythrocytes were lysed in equal volume of hypotonic solu-
tion (10mM Tris pH 7.6, 1mM EDTA, 20μg/mL PMSF) as
describedbyDodgeetal.[14].Membraneswererecoveredby
centrifugation at15,000rpmfor15minat4◦C inSS-34rotor
of Sorvall RC-5C centrifuge. The supernatant was preserved
as the cytosolic fraction. The pellet containing erythrocyte
membrane-skeletal fraction (referred to as membrane) was
given three washes with wash buﬀer to remove the cytosolic
proteins. Membrane as well as cytosolic fractions were
aliquoted and preserved at −70◦C until use. Protein was
estimated using the modiﬁed Lowry’s method [15].
2.5. Separation of Proteins by Sodium Dodecyl Sulfate-Pol-
yacrylamide Gel Electrophoresis (SDS-PAGE), Western Blot-
ting and Immunodetection of Band 3, Cathepsin G and PKC
βII. Erythrocyte membrane proteins (60μg) were resolved
on 10% SDS-polyacrylamide gels by electrophoresis and
then transferred to PVDF membrane [16]. The blots were
blocked with 5% nonfat dry milk in tris-buﬀered saline
containing Tween-20 (TBST) (10mM Tris, 150mM NaCl,
pH7.4containing Tween 20,0.2%, v/v)at roomtemperature
(RT) for 1h and subsequently incubated overnight at 4◦C
with appropriate primary antibodies in 2.5% nonfat dry
milk in TBST (anti-band 3 monoclonal, 1:5000;anti-band 3
polyclonal 1:1000; anti-cathepsin G 1:1000 dilution). After
washing with TBST, the blots were incubated with anti-
mouse HRP-conjugated secondary antibody with appropri-
ate dilutions prepared in 2.5% non-fat dry milk in TBST for
1h at RT. Following incubation, the blots were washed with
TBST and were developed with ECL plus reagent, and the
signal was recorded on X-ray ﬁlms. PKC βII was detected
similarly inthecytosolicfraction(120μg)usinganti-PKCβII
antibody (1:1000 dilution).
2.6. Detection of Erythrocyte Membrane Proteins Recognized
by Serum IgG. IgG was separated from sera using Melon
gel IgG puriﬁcation kit as per manufacturer’s instructions.
Membrane proteins (60μg) were resolved onpolyacrylamide
gels in duplicate. The resolved proteins from one of the
gels were transferred to PVDF membrane and probed with
serum IgG and the other gel was silver stained to be used for
identiﬁcationoftheantigenicproteinsbymass spectrometry.
Separation of proteins on SDS-PAGE, western blotting, and
immunostaining was done using the protocol described
above except for using 5μgo fI g Gs e p a r a t e df r o ms e r aa s
primary antibody and HRP-labeled anti-human IgG as the
secondary antibody. To detect proteins reacting with serum
IgG, each membrane sample was tested with IgG separated
from serum of the same individual.
2.7. Mass Spectrometric Identiﬁcation of Erythrocyte Surface
Antigen Bound by Serum IgG. The position of the band ob-
tained on the autoradiograph after immunostaining was
marked on the corresponding silver-stained gel, and the
gel piece was processed for mass spectrometry as described
earlier [17] except that the destained gel plug was reduced
with10mMdithiothreitolandalkylatedwith55mMiodoac-
etamide before trypsinization. One μL of the peptide digest
extracted from a gel piece was premixed with equal volume
of CHCA matrix and spotted on a matrix-assisted laser de-
sorption ionization (MALDI)plate. Peptide mass ﬁngerprintAnemia 3
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Figure 1: The proﬁle of band 3 in the membranes of normal and CML erythrocytes. Western-blotted membrane proteins of erythrocytes
(a–d) were stainedwithmonoclonalanti-band 3antibody. (a) The normalerythrocyte (N) showsthe parent band 3 moleculeat 95kDa,and
fragments at 55, 43, and below 26kDa. (b–e) CML samples designated as “C” showed varied degree of fragmentation of band 3 as shown
in (b) wherein parent band 3 is seen at 95kDa and all fragments observed in normal are additionally cleaved (c) in which parent band 3 is
not detected, and fragments detected in normalerythrocyte show greater intensity compared to the normalsample (d) where neither parent
molecule nor the fragments are detected; (e) the fragments not detected in the representative CML sample in (d) are stained by polyclonal
antibody to the whole band 3 molecule, thus indicating excessive cleavage of the N-terminal region which is detected by the monoclonal
antibody.
(PMF) data was acquired on the MALDI TOF-TOF (TOF:
time of ﬂight) mass spectrometer (Ultraﬂex II, Bruker Dal-
tonics, Germany) in the reﬂector mode. The data was
searched against Swiss-Prot database using MASCOT search
engine with a peptide mass tolerance of 100ppm.
2.8. Elucidation of the Role of Cathepsin G in Cleavage of Band
3. To study the action of cathepsin G on erythrocyte mem-
brane proteins, erythrocytes (108 cells/mL) from six healthy
volunteerswere incubated at 50◦Cf o r1 5m i ni naw a t e rb a t h
tosimulatestress conditions.The cells were thentreated with
IgG-depleted (using protein G sepharose adsorption) and
complement-inactivated (incubation at 50◦Cf o r3 0 m i n )
sera from healthy volunteers or CML patients in the
presence or absence of pepstatin A (1mg/mL) or cathepsin
G inhibitor I (53nM) at 37◦C for 20min. Thereafter, the
erythrocytes were lysed, the membrane fractions, prepared,
and protein, estimated as described earlier. The membrane
protein fractions were resolved on SDS-PAGE, transferred
on to PVDF membrane, and probed with anti-cathepsin G
(diluted 1:1000) and anti-band 3 (monoclonal) antibodies
as described earlier. The autographs with signals for band 3
were scanned using Epi-Chemi II gel documentation system
(UVP, UK) and densitometric analysis of signal in each well
was done using LabWorks software version 4.0.08.
3.Resultsand Discussion
3.1. Proﬁle of Erythrocyte Membrane Band 3 from CML Pa-
tients and Controls. Western blots of membranes prepared
from normal and CML erythrocytes were stained with mon-
oclonal anti-band 3 antibody. The band 3 proﬁle obtained
in representative normal samples is shown in Figure 1(a). It
is seen that in addition to the parent band 3 molecule at
approximately 95kDa, fragments were detected at around
55, 43, and below 26kDa in the normal erythrocyte samples.
Cleavage of membrane protein band 3 is reported to occur
in erythrocytes [18], and Kay et al. have shown that during
normal erythrocyte aging, limited proteolysis of band 3
generates peptides of 60, 42, and 18–26kDa [5], which is
similar to our observation. This fragmentation is attributed
to activation of membrane-bound proteases [19]. Caspase
3 ,w h i c hi sr e p o r t e dt ob ea c t i v ei na g e de r y t h r o c y t e s[ 20],
cleavesthe N-terminal region of band 3 to generate two frag-
ments of 18 and 21kDa [21] and can explain the detection of
a faint doublet observed below 26kDa in Figure 1(a).
Normal-like pattern of band 3 was observed only in 2/18
(11%) CML samples. The majority of CML samples (89%)
showed extensive fragmentation of band 3. Three diﬀerent
band 3 proﬁles were seen for CML samples (Figures 1(b),
1(c), and 1(d)). The membrane fractions of erythrocytes
from 13/18 CML samples showed either additional cleav-
age of the fragments observed in normal erythrocytes
(Figure 1(b)) or greater intensity of the fragments as com-
pared to the normal with near undetectable parent band 3
(Figure 1(c)). Three out of eighteen CML samples did not
stain with the monoclonal antibody as shown in the repre-
sentative samples in Figure 1(d). However, the fragments
were detected when the blot was stained with polyclonal
anti-band 3 antibody against the whole band 3 protein
(Figure 1(e)),whichindicatescleavageofN-terminaldomain
of the molecule, recognized by the monoclonal antibody.
Fragmentation of band 3 bears a physiological signiﬁ-
cance as distinct fragments are senescent cell antigens [5, 6],
which elicit immune recognition and phagocytosis of aged
erythrocytes. It was thus appropriate to investigate if the
fragment/s of band 3 detected in the membrane of CML
erythrocytes were recognized by serum IgG.
3.2. Antigens Recognized by Serum IgG in the Membranes of
Erythrocytes from CML Patients and Normal Individuals. To
determine whether serum IgG recognized any of the band
3 fragments, the western blots of membrane proteins from4 Anemia
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Figure 2: Detection of Antigens on erythrocyte membrane which are recognized by serum IgG. (a) autographs of western blots of
membranes of erythrocytes from CML patients designated C, and controls (N) stained with IgG separated from sera of the respective
individual have been shown. A 43kDa fragment is stained in normal and a larger number of CML while fragments at 55 and 26kDa are
stained mainly in CML erythrocytes. The antigens are identiﬁed as fragment of band 3 (43kDa), myeloperoxidase (55kDa), and cathepsin
G (26kDa) by mass spectrometry (details in Table 1). (b) The identity of cathepsin G was validated by immunostaining of western blots
of erythrocyte membranes with cathepsin G-speciﬁc antibody. CML samples show higher expression of cathepsin G. (c) Immunostaining
of blotted proteins from cytosol of normal and CML erythrocytes with PKC βII antibody shows a low-intensity band in both. PKC βII is
expressed in neutrophils but not in erythrocytes. Insigniﬁcantdetection of PKC βII inboth normalandCML samplesrules out thedetection
of cathepsin G due to contaminationof neutrophils in the erythrocyte preparation. Rat brain lysate is the positive control.
normalandCMLerythrocyteswereprobedwithIgGpuriﬁed
from the respective sera. Bands corresponding to those
detected by serum IgG were excised from a replicate silver-
stained gel and analyzed by mass spectrometry. The antibod-
iesrecognized animmunogenat43kDain3/8(38%)normal
and 6/9 (68%) CML samples (representatives in Figure 2(a),
lanesN16,C10,and C11),which wasidentiﬁedasa fragment
of band 3 by mass spectrometry (Table 1). Thus CML ery-
throcytes showed greater fragmentation of band 3 (Figures
1(b), 1(c), and 1(e)) as well as wider occurrence of immuno-
genic band 3 fragments (Figure 2(a)) and thereby eryptotic
phenotype. This is in keeping with the detection of a 45kDa
immunogenicfragment ofband3reportedbySantos-Silvaet
al. [2] in postmyocardial infarction patients and controls but
diﬀersfrom the report on the recognition of a 62kDa band 3
fragment by IgG eluted from aged erythrocytes by Kay [6].
Additionally, proteins at 55kDa and 26kDa were rec-
ognized by serum IgG in 8/9 samples from CML patients
(Figure 2(a)) and only 3/6 healthy volunteers (Figure 2(a),
representative in lane N16). The molecules at 55kDa and
26kDa, which were detected by serum IgG in the majority
of CML samples, were identiﬁed as myeloperoxidase and
cathepsin G, respectively, by mass spectrometry (Table 1).
Both proteins are abundant in azurophilic granules of neu-
trophils and are not expressed in erythrocytes.
Toconﬁrm thepresenceofcathepsinGintheerythrocyte
membranes, the western-blotted membrane proteins from
normal and CML samples were probed with anti-cathepsin
Ga n t i b o d y .Figure 2(b) shows that cathepsin G was detected
mainly in CML samples. The possibility of neutrophil con-
tamination contributing to the increased cathepsin G levels
in CML erythrocyte membrane preparations was ruled out
by demonstrating nondetection of PKC βII (Figure 2(c)),
which is present in neutrophils [22]b u tn o te r y t h r o c y t e s
[23]. The detection of cathepsin G, which is a protease, in
erythrocyte membranes with excessively fragmented band 3
suggested a possible role of the former in the fragmentation
of the later.
3.3. Adsorption of Serum Cathepsin G to Erythrocyte Mem-
branes and Cleavage of Band 3. Detection of the neutrophilic
cathepsin G on erythrocyte membrane required investiga-
tions on its source. Stimulated neutrophils are known to
release elastase and cathepsin G in the surrounding medium
[24] and stressed erythrocytes adsorb proteins from body
ﬂuids [25]. In this study, stress condition was simulated
by incubation of normal erythrocytes at 50◦Cf o r3 0 m i n ,
and the stressed erythrocytes were further exposed to IgG-
depleted/complement-inactivated sera from CML patients
and normal controls.
Erythrocytesfromhealthyvolunteersincubatedwithsera
from CML patients showed higher levels of membrane cat-
hepsin G as compared to those incubated with sera from
controls as shown in Figure 3(a). Cathepsin G being a serineAnemia 5
Table 1: Mass spectrometric identiﬁcation of erythrocyte membrane antigens recognized by serum IgG. Trypsin digests of protein spots
in gels of erythrocyte membranes, at a position corresponding to signals for immunogens recognized by serum IgG in the western blot of
a replicate gel, were subjected to mass spectrometry. Peptide mass ﬁnger print (PMF) data was acquired on the MALDI TOF-TOF Protein
analyzer (Ultraﬂex II, Bruker Daltonics) in the reﬂector mode. The data was searched against SwissProt database using MASCOT search
engine with a peptide mass tolerance of 100ppm.
Molecular weight
in SDS-PAGE Sample Accession no. pI Molecular
weight in kDa Score Sequence
coverage
Peptides matched
(submitted) Protein identity
55kDa
CML 10 PERM H 9.19 84.7 118 14% 11 (14)
Myeloperoxidase CML 11 PERM H 9.19 84.7 94 11% 8 (10)
CML 13 PERM H 9.19 84.7 61 8% 6 (15)
CML 14 PERM H 9.19 84.7 70 8% 7 (13)
43kDa
N6 B3AT H 5.08 102 74 11% 7 (22)
Band 3 anion
transport protein N11 B3AT H 5.08 102 66 19% 14 (52)
CML 11 B3AT H 5.08 102 50 17% 10 (48)
26kDa
CML 12 CATG H 11.19 29.1 64 17% 5 (11)
Cathepsin G CML 13 CATG H 11.19 29.1 71 26% 6 (17)
CML 14 CATG H 11.19 29.1 64 25% 6 (29)
CML 16 CATG H 11.19 29.1 70 22% 7 (25)
Erythrocyte
sample:
Incubated with
serum from:
Cathepsin
inhibitor:
N2 N2 N3 N5
N2 N2 N2 N2 C6 N3 C10 N5 C13 C5 C5 C5
—— —— —— — p e p pep Cl Cl
20kDa
20kDa
0.05 0.07 0.06 0.07 0.07 0.06
—
(a) Probed with cathepsin G (c) Probed with band 3
(b) Probed with band 3
Figure 3: In vitro studies to delineate the role of cathepsin G in the proteolysis of band 3. Heat-stressed normal (N) erythrocytes were
incubated with IgG-depleted/complement-inactivated sera from the same individual and also with sera from CML patients designated C
(N2 with C6, N3 with C10 and N5 with C13) at 37◦C for 20 min. Western blots prepared from the lysates of these erythrocytes were stained
with cathepsin G and band 3 antibodies. (a) Cathepsin G levels are higher in the membrane of erythrocytes incubated with CML sera
as compared to normal sera. (b) Staining of the same blot with anti-band 3 antibody shows that a 20kDa fragment of band 3 is seen in
cells incubated with CML sera. (c) The generation of 20kDa fragment is diminished upon incubation with pepstatin A (pep) and is nearly
inhibited by cathepsin G inhibitor 1 (CI). Densitometric readings of each lane of the band 3 autograph corresponding to the lanes in (c)
demonstrate equal loading.
protease, the natural sequel to this observation was to inves-
tigate if cathepsin G had a role in the cleavage of band 3
in CML erythrocytes. The same set of samples was probed
with anti-band 3 antibody. Figure 3(b) shows that a band 3
fragment at approximately 20kDa is detected in membranes
of erythrocytes incubated with sera of CML patients with a
band of lower intensity detected only in 1/3 samples incu-
bated with normal serum (N3 in Figure 3(b)). Incubation
with sera from normal or CML patients in the presence of
p e p s t a t i nA ,w h i c hc a ni n h i b i tc a t h e p s i nEk n o w nt ob ee x -
pressed inerythrocytes[26],causedmoderatedecreaseinthe
generation of the 20kDa fragment of band 3 (Figure 3(c)).
Inhibition of generation of a 55kDa fragment of band 3
by pepstatin A is reported in Ca2+-enriched erythrocytes
[27]. In our study, a near complete inhibition of formation
of the 20kDa fragment was observed upon incubation of6 Anemia
erythrocyte with either normal or CML sera in the presence
of cathepsin G inhibitor 1 (Figure 3(c)) which demonstrated
the involvement of serum cathepsin G in the cleavage of
band 3 in vitro. The densitometric values for the band 3
signals for each lane as shown below Figure 3(c) indicated
equal detection of total band 3 in the presence and absence
of pepstatin A and cathepsin G inhibitor 1. This conﬁrmed
that the inhibition observed was not an artifact of unequal
loading.
Although neutrophilic elastase has been shown to cleave
erythrocyteband3[7],oursistheﬁrstreportoninvolvement
of cathepsin G in the proteolysis of band 3. In contrary to
our observation, Bykowska et al. [8]h a v es h o w nt h a tb a n d3
is partially digested by elastase but is resistant to cleavage by
cathepsin G. The diﬀerence could be due to the use of pure
cathepsin in their study against serum used in our investiga-
tion, which contains several molecules other than cathepsin
G. It can be speculated that factors other than cathepsin G in
serumcouldcauseexposureofacrypticsiteonband3,which
is proteolyzed by cathepsin G. It is also possible that cleav-
age of glycophorin by cathepsin G removes steric “shield-
ing” of band 3 by the adjacent glycophorins [28], thereby
allowing cleavage of band 3 by another protease, such as
elastase.
4.Conclusion
Thus,co-occurrenceofextensivelycleavedband3andadher-
ent cathepsin G on the membranes of CML erythrocytes,
along with the in vitro demonstration ofthe role ofcathepsin
Ginproteolysisofband3,indicatesinvolvementofcathepsin
Gi nba n d3cl ea v a gein vivo.Moreover, the excessive cleavage
of band 3 in CML correlates with greater detection of im-
munogenic fragments of band 3, indicative of eryptotic
phenotype. Thus, cathepsin G-mediated proteolysis of band
3 could exemplify a mechanism for the generation of eryp-
totic phenotype in CML.
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